Status:
COMPLETED
Taste Properties of Atazanavir and Cobicistat
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
HIV in Adults
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The primary objective is to assess the taste properties of atazanavir (ATV) and cobicistat (COBI) alone and in combination as well as oral test formulations containing both ATV and COBI.
Eligibility Criteria
Inclusion
- For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
- Men and women, ages ≥18 years
- Subjects who are qualified professional sensory panelists
- Healthy subjects as determined by no clinically significant deviation from normal in medical history and physical assessment
Exclusion
- Any acute or chronic condition that may alter taste or smell sensory perception
- Any significant acute or chronic medical illness or any surgery within 4 weeks of the study drug administration
- Positive HIV test using an oral swab kit (such as OraQuick®) to detect HIV-1 or -2 antibody
Key Trial Info
Start Date :
December 12 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2021
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT02307656
Start Date
December 12 2014
End Date
September 9 2021
Last Update
January 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Senopsys Llc
Woburn, Massachusetts, United States, 01801